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ABSTRACT  Veratridine  modification  of  Na  current  was  examined  in  single 
dissociated ventricular myocytes from late-fetal rats by applying pulses to  -30  mV 
for 50 ms every 2 or 5 s from a holding potential of -100 mV (20°C) and measuring 
amplitude,/tail, and time constant, ~taU, of the post-repolarization inward tail current 
induced by the alkaloid. Increasing the pH of a 30 ~M veratridine superfusate from 
7.3 to 8.3 (which increases the fraction of uncharged veratridine molecules from 0.5 
to 5% while decreasing that of protonated molecules from 99.5  to 95%) increased 
/tail  by  a  factor  of  2.5  -+  0.5  (mean-+ SEM;  n  =  3).  Switching  from  100  ~M 
veratridine superfusate at pH 7.3 to  10 0.M at pH 8.3 did not affect the size of/tail 
(n =  4). Intracellular (pipette) application of 100  I~M veratridine at pH 7.3 or 8.3 
produced  small  l~aa'S suggesting  transmembrane  loss  of  alkaloid.  If  this  was 
compensated for by simultaneous extraceUular application of 100 ~M veratridine at 
a  pH  identical  to  intracellular  pH,  /tail  (measured  relative  to  the  maximum 
amplitude induced by a combination of 100 ~.M veratridine and  1 I~M BDF 9145 in 
the same cell) at phi 7.3 did not significantly differ from that at pHi 8.3 (84 ±  4 vs. 
70 ±  6%; n  =  3 each). Results from six control cells and five cells subjected to extra- 
and/or intracellularly increased viscosity by the addition of 0.5  or  1 molal sucrose 
showed that increasing intracellular viscosity 1.6- and 2.5-fold increased ~tait 1.5- and 
2.3-fold, respectively, while a selective 2.5-fold increase of extracellular viscosity did 
not  significantly  affect  xtail. Superfusion  with  the  related  ceveratrum  alkaloid 
cevadine (1-100  ~M), in cells additionally treated with  1 tzM BDF 9145 to remove 
inactivation, induced a  tail current whose amplitude was half-maximal at 4  ~M and 
saturating at 30  ILM, while rtaa (mean value 49 ms; eight cells) was not affected by 
concentration. The addition of 100 or 30 ~M cevadine to the superfusate containing 
a  saturating concentration  of veratridine  (30  IxM)  had  little effect on  the  initial 
amplitude of the veratridine-induced tail current, but converted its monoexponen- 
tial decay into a biexponential decay characterized by time constants corresponding 
to cevadine and veratridine, respectively. The veratridine-induced component of/tail 
was reduced to 25% by 100 ~M cevadine (n =  1) and to 60 -+ 7% (n =  3) by 30 ~M 
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cevadine. We conclude on the basis of the extracellular and intracellular pH and 
viscositiy effects that extracellularly applied veratridine diffuses in its free base form 
through the sarcolemma and activates the Na channel at an intracellular site in its 
protonated form. This action  is mutually exclusive with that of cevadine, the C-3 
angelic  acid  ester  analogue  of veratridine,  suggesting  a  competitive  interaction. 
Chemical complementarity of veratridine to its binding site suggests the intracellu- 
lar presence of a negative charge and adjacent hydrophobic amino acid residue as 
essential components of the veratridine recognition site at the Na channel macro- 
molecule. 
INTRODUCTION 
Recent  biochemical  and  electrophysiological  work  on  the  voltage-dependent  Na 
channel  has led  to  the  identification  of individual  amino acids within  the  channel 
macromolecule that are involved in  the binding  of scorpion  toxin,  tetrodotoxin  or 
saxitoxin, and Zn  ~+ ions (Tejedor and Catterall,  1988; Thomsen and Catterall,  1989; 
Noda, Suzuki, Numa, and Stfihmer,  1989; Schild and Moczydlowski,  1991). 
Detailed characterization of such binding sites,  including  their localization to the 
extra-  or  intracellular  side,  structure-activity  relationships,  and  resolution  at  the 
individual amino acid level in conjunction with knowledge of the biophysical effects of 
the  ligand  may help  to  define  structure-function  relationships  of the  Na  channel 
macromolecule. The location and chemical properties of the binding site for a widely 
used class of Na channel  activators, veratridine,  and  other ceveratrum alkaloids,  is 
still largely unknown. Analysis of this topic is complicated by the low affinity of these 
alkaloids, by their ability to diffuse through the plasmalemma, thereby reaching the 
membrane  side  opposite  to  that  of  application,  and  by  their  existence  in  two 
molecular forms, protonated and free base. 
In  this  study  on  whole-cell  Na  current  in  rat  ventricular  cardiomyocytes,  we 
determine  the  active  form  of  veratridine,  the  sidedness  of  its  action,  and  its 
interaction  with  a  closely  related  ceveratrum  alkaloid,  cevadine.  The  results  are 
consistent with an intracellular binding site that is exposed only during activation of 
the Na channel and to which veratridine binds reversibly in its protonated from. Na 
channel  modification  by  veratridine  will  be  shown  to  be  mutually  exclusive  with 
cevadine. Complementarity to the positive charge on veratridine and to the hydro- 
phobicity of the C-3 veratric acid ester group suggest an intracellular anionic amino 
acid side chain in proximity to a hydrophobic residue as essential components of the 
veratridine  binding  site.  With  the  primary  structure  of the  rat  heart  Na  channel 
known  (Rogart,  Cribbs,  Muglia,  Kephart,  and  Kaiser,  1989;  Cribbs,  Satin,  Fozzard, 
and  Rogart,  1990;  Kallen,  Sheng,  Yang,  Chen,  Rogart,  and  Barchi,  1990),  experi- 
ments can be designed to test these conclusions at the molecular level. 
METHODS 
Whole-cell Na current was recorded from cultured rat ventricular cardiomyocytes  as described 
in the preceding paper (Zong, Dugas, and Honerj~iger,  1992). 
The experiments were carried out in the Petri dish used for culturing and filled with 2-3 ml 
solution  kept at  19.5-20.5°C  by a  Peltier  element device  (npi Advanced  Electronic  Systems, 
Eching  a. A., Germany). The pipette contained the following intracellular  solution  (mM): 108 HONERJ3,GER El"  AL.  lntracellular  Action of Veratridine and Cevadine  701 
CsCI, 14 NaCI, 2 MgCI2, 1 CaCI2,  11 EGTA, 10 glucose, 10 HEPES, 25 CsOH, and 0.3 NaOH 
(pH 7.3). Additional CsOH was used for alkalinization to pH 8.3. Extracellular Na was reduced 
to improve the  quality of the voltage clamp,  extracellular Ca was reduced  to  minimize C~t 
current and contractions, and Cs was used to block K currents. The extracellular bath solution 
contained (mM): 69 NaCI, 69 CsCI,  5.4 KCI, 2 MgCiz, 0.1  CaCI2,  10 glucose, 10 HEPES, and 
1:1  NaOH and CsOH as required for pH 7.3 or 8.3. The viscosity of the medium in contact 
with the extra- or intracellular side of the cell membrane was increased by addition of sucrose, 
and osmotic effects of sucrose were avoided by addition of equimolar urea, which does not 
increase viscosity, to  the  solution  at  the  opposite  side  of the  cell  membrane.  Since  high 
concentrations of these nonelectrolytes were required, molal (m) rather than molar concentra- 
tions were prepared. The cell under investigation was either studied after equilibration with the 
bathing solution or during continuous superfusion by a microsuperfusion device described in 
the preceding paper (Zong et al., 1992).  The amplitude of the veratridine-induced tail current, 
/tail,  was  measured 10 ms after repolarization. 
Veratridine base (Sigma, Miinchen, Germany) and cevadine base (a gift from the late Dr. O. 
Krayer) were converted into the hydrochlorides by addition of HCI and dissolved in extracellu- 
lar  medium  (their  chemical  structures  are  shown  in  Fig.  1).  BDF  9145,  obtained  from 
OCH  3 
Veratridine, R= -~ OCH  3  CH3H 
Cevadine,  R  =  -CH=3cl  H  11  N  "~ 
c%  L  --c"3 
:  OH 
.co- 
OH 
FIGURE  1.  Chemical structure of the 
free base form of veratridine and cev- 
adine, which differs from veratridine 
only  in  its acid moiety (angelic acid 
instead  of veratric acid  esterified to 
the parent alkamine, veracevine). 
Beiersdorf AG (Hamburg, Germany), is 4-(3-(4-((4-cyanomethoxyphenyl)phenylmethyl)-l-pip- 
erazinyl)-2- hydroxypropoxy)-lH-indole-2-carbonitrile  and was dissolved in dimethylsulfoxide 
(1 mM; final concentration, 1 pLM). 
Where  appropriate, results are presented  as mean  +-  SEM.  Student's t  test for unpaired 
values was used in Table II. 
RESULTS 
Increase of ExtraceUular pH 
Veratridine  is  a  weak  base  with  pK~  determined  as  9.7  (Biich,  1976)  or  9.54 
(McKinney, Chakraverty,  and  De Weer,  1986).  Taking pKa as 9.6,  the  Henderson- 
Hasselbalch equation yields the following ratios of protonated charged to uncharged 
(free base) molecules at different pH values: 
pH 7.3:200 
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Increasing the pH of a veratridine solution from 7.3 to 8.3 thus increases the fraction 
of uncharged veratridine molecules 10-fold, from 0.5 to 5%, while that of protonated 
molecules decreases only slightly, from 99.5 to 95%. The term ionization will be used 
to describe the degree of protonation of veratridine, while the term dissociation will 
denote the unbinding of veratridine from its receptor at the Na channel. 
In the absence of veratridine, changing the extracellular pH between 7.3 and 8.3 
did  not  affect  peak  Na  current  elicited  by  our  standard  pulse  protocol  (50-ms 
depolarization to -30 mV from -100 mV holding potential every 5 s; n  =  3) in line 
with the insensitivity of frog node of Ranvier Na current over this range of pHo (Hille, 
1968). 
We first tested the possible role of uncharged veratridine molecules by applying 30 
~M  veratridine  at  the  standard  pH  of  7.3  and  then  switching  the  pH  of the 
veratridine superfusate to 8.3 (Fig. 2). The superfusate exchanges the environment of 
the  cell within  ~ 0.1  s.  In  contrast,  the  veratridine  effect developed  much  more 
slowly,  reaching a  steady state only after  ~ 1.5  rain. This slow  development of/tail 
does not represent slow association of veratridine to its receptors. Rather,  each/tail 
point is proportional to the number of Na channels to which veratridine associated 
during the  immediately preceding 50-ms  depolarization (Sutro,  1986;  Zong et al., 
1992). The tail current itself reflects veratridine dissociation, and the dissociation is 
complete long before the next pulse (Zong et al.,  1992)./tail is thus a measure of the 
"effective" veratridine concentration prevailing during each 50-ms pulse. Clearly, this 
effective concentration does not reflect the extracellular concentration, which reaches 
its steady-state level within 0.1  s. The delayed response to extracellular veratridine 
application argues against an extracellular site of action of this alkaloid. 
As shown by Fig. 2, increasing pHo to 8.3 after stabilization of the veratridine effect 
at pH  7.3  resulted in a  delayed and  eventually 3.4-fold increase of Itaiz, which was 
reversible  upon  reacidification.  Results  of three  experiments  are  summarized  in 
Table I A. The tail current time constant was  not consistently affected by the  pHo 
change (Fig. 2, Table I A ). The increase of/tail by a factor of 2.5 -  0.5 upon elevation 
of pHo to 8.3 is consistent with the augmentation induced by a  10-fold increase in 
veratridine concentration (from 30 to 300  ~M)  at a  constant pHo of 7.3  (Fig.  3  in 
Zong et al.,  1992). This result suggests that uncharged veratridine, which increases 
from 0.15 to 1.5  o.M ifpH is increased from 7.3 to 8.3 at 30 v.M total veratridine, is 
responsible for inducing  the  tail  Na  current during extracellular application.  The 
possible  additional  contribution  of extracellular protonated veratridine  molecules, 
although unlikely because of the slow onset, was tested by a maneuver that alters the 
concentration  of charged  veratridine  without  affecting  that  of the  free  base.  A 
concentration of 100 p.M veratridine was superfused at pH 7.3, followed by simulta- 
neous reduction of veratridine concentration to 10 o.M and an increase of pH to 8.3. 
As shown by Fig.  3, there was  no change of Itaii during this solution change where 
extracellular  charged  veratridine  is  reduced from  99.5  to  9.5  vLM  at  constant 
uncharged veratridine concentration (0.5  ~M). This lack of effect was confirmed in 
three  additional  experiments  performed  in  reversed  sequence  (Table  I B).  We 
conclude  that  the  cardiac  Na  channel  is  insensitive  to  extracellular  protonated 
veratridine molecules although this molecular species is  present in 200-fold excess 
over the free base form at physiological pH. HONERJ~,GER ET AL.  lntraceUular Action of Veratridine and Cevadine 
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FIGURE 2.  Increasing extracellular pH  augments effect  of superfused  veratridine on  Na 
current in a single embryonic rat cardiomyocyte. (A) Plot of/tail  elicited by 50-ms depolariza- 
tions to -30 mV at 0.2 Hz from -100 mV holding potential (filled  symbols) and lhoia (open 
symbols)  as  a  function of time  immediately before  and  during  superfusion with  30  I~M 
veratridine  as  indicated  in  the  upper  bar.  After  veratridine  application  at  the  standard 
extracellular pH  of 7.3 until a  steady-state effect  was established, the microsuperfusion was 
switched  to solution containing the same veratridine concentration at pH 8.3 and later back to 
the initial veratridine solution. Note the threefold increase in Itail at the higher pH value, its 
reversibility, and the  delayed response to  extraceltular pH  changes which were  completed 
within  < 0.1  s.  (B)  Na  tail current records  from  the  same  experiment before  veratridine 
application (a) and after equilibration  with 30 ~.M veratridine at pH 7.3 (b) and pH 8.3 (c). Peak 
lNa was truncated. 704  THE JOURNAL OF  GENERAL PHYSIOLOGY • VOLUME 99 • 1992 
Increase  of Intracellular pH 
Because the foregoing experiments  excluded  an extracellular site of action of either 
form of veratridine, we next examined  the possibility of an intracellular site of action. 
Fig. 4 A, trace a, shows the tail current induced by intracellular application of 100 ~M 
veratridine  at  pH  7.3  via  the  patch  pipette.  /tail  was  quantified  as  27%  of  the 
maximum/tail produced  later in the same cell by additional extracellular superfusion 
with  100  ~M veratridine and  1  lzM BDF 9145  (trace c), a  condition that modifies all 
Na  channels  of the cell as  described  in  the  preceding  paper  (Zong et  al.,  1992).  In 
three  experiments,  Itail  amounted  to  36  -  6%  of maximum  /tail.  Fig.  4  B,  trace  a, 
TABLE  I 
Effect  of ExtraceUular pH on  Veratridine-induced Tail Current 
(A) Change of pH from 7.3 to 8.3 during superfusion  with 30 o.M veratridine 
pH 7.3  pH 8.3  pH 7.3 
Cell  /till  'rtail  /tail  "ttail  /tail  "rtail 
a  b  b/a  c  c/a 
-hA  ms  -hA  ms  -hA  ms 
Z93  0.20  197  0.33  1.6  186  0.20  1,0  183 
Z94  0.19  156  0.46  2.4  165  0.17  0.9  152 
Z95  0.25  229  0.86  3.4  265  0.42  1.6  253 
Mean ± SEM  --  194 ± 21  --  2.5 ± 0.5  205 ± 30  --  1.2 ± 0.2  196 -  30 
(B)  Simultaneous  change of pH and veratridine concentration 
10 IzM veratridine  100 I~M veratridine 
at pH 8.3  at pH 7.3 
Cell  ltail  7tail  ltail  'v~iI 
a  b  a/b 
-hA  ms  -hA  ms 
Z71  0.68  206  0.56  1.2  214 
Z72  0.22  242  0.23  1.0  211 
Z73  0.54  210  0.60  0.9  210 
Z70*  0.55  221  0.56  1.0  230 
Mean ± SEM  --  220 ± 82  --  1.0 ± 0. I  216 ± 5 
*Sequence reversed in this experiment. 
shows  the  tail current  induced  by intracellular  application  of 100  ~M veratridine  at 
pH  8.3.  While  maximum/tail  was  comparable  in  cells A  and  B,  sole  application  of 
intracellular  veratridine  at  pH  8.3  produced  a  smaller  /tail  (17%  of maximum)  as 
compared  with  that  at  pHi  7.3.  This  difference,  amounting  to  a  factor  of 2.3  on 
average, was  statistically significant (Table IIB). 
The pHi dependence  ofveratridine action during intracellular application was thus 
opposite to the pHo dependence  during extracellular application. While extracellular 
tests pointed to an exclusive role of the free base form, but excluded an extracellular 
site of action,  the intracellular results  rule out that the free base form is active either 
from  inside  the  membrane  or after diffusion  into  the  lipid phase  of the  membrane, HONERJ~.GER ET AL.  IntraceUular  Action of Veratridine and Cevadine  705 
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FIGURE 3.  Increasing extracellular  pH  compensates  for  reducing extracellular veratridine 
concentration. (A) Plot of/tail elicited by 50-ms depolarizations at 0.5 Hz to -30 mV from -  100 
mV holding potential (filled symbols) and/hole (open symbols) as a function of time immediately 
before  and during superfusion with veratridine as indicated in the upper bar. The  first  few 
pulses in veratridine were not recorded. After application of 100 gtM veratridine at the standard 
extracellular pH  of 7.3 until a  steady-state  effect was  established,  the  microsuperfusion was 
switched to solution containing one-tenth of the veratridine concentration at a  pH of 8.3. (B) 
Na tail current records from the same experiment before veratridine application (a) and after 
equilibration with I00 izM veratridine at pH 7.3 (b) and subsequently 10 p,M veratridine at pH 
8.3 (c). Peak INa was truncated. Record a  contaminated by veratridine leakage. 706  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  -  VOLUME  99  •  1992 
because  Na  channel  modification  decreased  despite  a  10-fold  increase  of  the 
intracellular  free  base  form  (from  0.5  I~M  at  pH  7.3  to  5  vLM at  pH  8.3).  Hence, 
uncharged veratridine molecules mediate the action during cell superfusion, but they 
are not the active molecular species. We propose that veratridine acts from inside the 
membrane in its protonated form. 
The loss of activity resulting from intracellular alkalinization  during patch pipette 
application  (Fig. 4, Table II) despite a  nearly unchanged concentration  (99.5  IxM at 
pH 7.3, 95 I~M at pH 8.3) can be explained by pH-dependent loss of veratridine via 
its free base form across the cell membrane.  For a  typical 20-l±m-diam spherical cell, 
the cell membrane area (1,260  txm  2) is  250-fold larger than the tip opening area of 
q 
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FIGURE 4.  Increasing intracellular pH has little  effect on intracellularly  applied veratridine. 
Na current records from two different cells (A, B) depolarized by 50-ms pulses at 0.2 Hz to -30 
mV from -100 mV holding potential.  (A) Record a was obtained  1 min after establishing the 
whole-cell clamp configuration with a  pipette filled with  100  I~M veratridine  at the standard 
intracellular pH of 7.3. The veratridine-induced tail current had remained  stable at the level 
shown  since  the  initial  amplifier  adjustments.  Record  b  was  obtained  1.5  min  later  after 
additional extraceilular superfusion with 100 I~M veratridine at pH 7.3 and stabilization of the 
tail current. Record c was taken another 1.5 rain later after addition of 1 I~M BDF 9145 to the 
extracellular  veratridine-containing  superfusate.  The  resulting  tail  current  represents  the 
maximum veratridine effect on this cell. (B) The protocol for obtaining records a, b, and c was 
identical to that described for A except that intra- and extracellular pH was 8.3. 
the  patch  pipette  (~ 5  ~m  2)  through which veratridine  diffuses  into  the  cell,  thus 
providing a  large area for diffusional loss. Transmembrane  loss of veratridine via its 
free  base  form  can  be  compensated  for by  additional  extracellular  application  of 
veratridine  at the same pH and concentration chosen for the pipette filling solution. 
If loss occurs, the additional extracellular application should increase the veratridine 
effect. As shown by Fig. 4  and Table II, veratridine  superfusion did in fact markedly 
augment  /tail,  by a  factor of 2.3  at  pH  7.3  and  4.4  at  pH  8.3.  Relative  /tail  during 
simultaneous  intra-  and  extraceUular  application  of veratridine  at  pH  7.3  was  not 
significantly different from that at pH 8.3 (Fig. 4, Table II). This is consistent with an 
intracellular site of action of the protonated veratridine  molecule. HONERJ.KGER  ET AL.  lntraceUular Action of Veratridine  and Cevadine  707 
Increase  of Intracellular  Viscosity 
Altering the viscosity of the reaction medium is a valuable tool to identify and localize 
diffusion-controlled  reactions  (Schurr,  1970;  Miller,  1990).  The  rationale  of this 
approach  is  based  on  the  Stokes-Einstein  relation,  which  states  that  the  diffusion 
coefficient  (D)  of a  solute  of effective radius  r  varies  inversely with  the  medium 
viscosity ('q): 
D  =  kT/6~rr,t  i 
where k is the Bohzmann constant and T is temperature. Since an increase in viscosity 
impedes both association and dissociation (Schurr,  1970), our concept of veratridine 
action predicts  that an increase of intracellular viscosity should  slow dissociation of 
TABLE  II 
Effect of lntraceUular pH on Veratridine-induced Tail Current 
(A)  IntraceUular and extracellular pH  7.3 
Plus veratridine 
Veratridine  Plus veratridine  and BDF 9145 
intracellularly  extracellularly  extracellularly 
/tail  Itail  /tail 
-hA  % of max.  -hA  % of max.  -hA  % 
Z159  0.45  32.8  1.04  76.5  1.36  100 
ZI60  0.63  47.6  1.18  89.4  1.32  100 
Z161  0.39  26.6  1.27  87.6  1.45  100 
Mean -+ SEM  --  36 ±  6  --  84 +- 4  --  -- 
(B)  Intraceilular and extracellular pH 8.3 
Z156  0.22  16.5  1.09  82.0  1.33  100 
Z157  0.18  ~.9  1.08  60.3  1.79  100 
Z158  0.43  21.1  1.37  67.5  2.03  100 
Mean ~  SEM  --  16 ±  3*  --  70 --- 61  --  -- 
Veratridine concentration  =  100 I,  LM; BDF 9145  =  1 I~M. 
*Significantly different from pH 7.3 (P  <  0.05). 
~Not significantly different from pH  7.3 (P >  0.1). 
veratridine from its putative intracellular binding site into the intracellular medium 
and therefore slow down the decay ofveratridine-induced tail current, while extracel- 
lular  viscosity  changes  should  not  affect  its  time  constant.  Fig.  5  compares  tail 
currents  from  four  different  cells,  each  of which  was  superfused  with  100  I~M 
veratridine plus  1 IxM BDF 9145 for 1.5-3 min. Cell A served as control and Ttail was 
0.24  s.  The  superfusate  on cell  B  contained  1 m  sucrose  to  increase  extracellular 
viscosity, and the pipette was filled with 1 m urea to prevent osmotic shrinkage of the 
cell. The resulting ~tail was identical  to that of the control cell.  Cells C  and D were 
treated  identically,  the  superfusate  containing  1  m  urea  and  the  pipette  solution 
containing  1 m  sucrose  to  increase  intracellular  viscosity.  Evidently,  this  treatment 
resulted  in a  slowing of tail current decay. The tail currents  of both cells were well 
described by a monoexponential function with ~tail =  0.51  s. Results from six control 708 
t 
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FIGURE 5.  Veratridine-induced  tail  current  is  slowed  by  increased  intracellular,  but  not 
extracellular, viscosity. Na tail current records from four different cells (A-D) depolarized by 
50-ms pulses at 0.2 Hz to -30 mV from -100 mV holding potential. Each cell was superfused 
with  100  I~M veratridine for 2-3 min  in the presence of 1 ~M  BDF 9145.  (A) Control. (B) 
Superfusate contained  1 m sucrose and the intracellular solution contained  1 m urea.  (C, D) 
Intracellular solution contained 1 m sucrose and the superfusate contained I m urea. 
cells and  five cells subjected to  extra- and/or  intracellularly increased viscosity are 
summarized  in  Table  III.  Increasing  the  intracellular  viscosity  1.6-  and  2.5-fold 
increased 'ttail 1.5- and 2.3-fold, respectively. 
Cevadine Effect  on Cardiac Cell Na Current 
The  concept  of saturable veratridine binding to  the  Na channels  of single cardiac 
cells (Zong et al.,  1992) would be further strengthened if similarly structured ligands HONERJ*GER  ET AL.  Intracellular Action of Veratridine  and Cevadine  709 
were  shown  to  compete  with  veratridine  for  a  common  binding site. We  therefore 
characterized the effect of cevadine (Fig.  1) on cardiac cell Na current (Fig. 6 A ). This 
cell  was  also  treated  with  1  v.M  BDF  9145  to  remove  inactivation.  Similar  to 
veratridine (cf.  Fig. 4  of Zong et al.,  1992),  cevadine induced (a) a  progressive decay 
of the  noninactivating Na  current  during  the  50-ms  depolarization  and  (b)  a  tail 
current whose  amplitude  increased with  cevadine  concentration.  As  in  the  case  of 
veratridine, the tail current decayed monoexponentially, but with a  distinctly shorter 
time constant, 41-44  ms in the cell of Fig. 6A. 
The  dependence  on cevadine  concentration of lt~il  and  ~tail determined  in eight 
cells is shown in Fig.  6, B  and C.  Half-maximally effective concentration for/tail was 
TABLE  Ill 
Effect of Extracellular and Intracellular  Viscosity on Time Constant "r of 
Veratridine-indwced Tail  Current 
Cell  "r  ~t/~c  ('qt/'qc)i  ('qt/'qc)e 
ms 
Controls 
Z165  212 
Z166  227 
Z169  242 
Z170  245 
Z171  175 
Z172  239 
Mean -  SEM  223 -+ 11  1.0  1.0  1.0 
0.5 m sucrose intracellularly and extracellularly 
Z206  333  1.5  1.6  1.6 
1 m sucrose extracellularly* 
Z210  245  1.1  1.0  2.5 
Z211  268  1.2  1.0  2.5 
I m sucrose intracellularly * 
Z212  510  2.3  2.5  1.0 
Z209  505  2.3  2.5  1.0 
All experiments were done in the presence of 100 o.M veratridine and 1 IxM BDF 9145 
applied extracellularly,  i, intracellular;  e, extracellular;  t, experiments with sucrose- 
containing solutions; c, control experiments. Relative viscosity, rl, for sucrose-contain- 
ing solutions was taken from Weast (1988). 
*Intracellular  solution contained 1 m urea. 
*Extracellular solution contained 1 m urea. 
4  ~M. 'rtail did not change with cevadine concentration (1-100  ~M) and the average 
was 49 ms (i.e., 22% of'rtai  I induced by veratridine [226 ms, Zong et al., 1992]). In three 
cells  examined  in  the  absence  of BDF  9145,  cevadine  (10-30  ~M)  induced  a  tail 
current with similar time constant (T =  44 _  1 ms). 
If veratridine and cevadine compete for a  common  intracellular site,  the effect of 
extracellularly applied cevadine, which has the same pKa value as veratridine (Shanes 
and  Gershfeld,  1960),  should  also  increase with  an  elevation  of pHo.  Two  experi- 
ments analogous to Fig. 2A using 10 ~M (n =  1) or 30 ~M cevadine (n =  1) gave a  2- 
and  1.6-fold augmentation of Itail,  respectively, upon  elevating pHo from  7.3 to  8.3. 710 
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FIGURE 6.  Effect of cevadine on cardiomyocyte Na current. All data from cells additionally 
equilibrated with 1 IxM BDF 9145. (A) Na currents elicited by 50-ms depolarizations to -30 mV 
from -100 mV holding potential (0.2 Hz) in the presence of 1 I~M cevadine (bath-applied, a) 
and after 2-min superfusion with 10 I~M (b) and 30 I~M cevadine (c). Tail currents were fitted by 
monoexponential functions with "r  =  0.041  s (a),  0.043 s (b), and 0.044 s (c). (B) Relative /tail 
(mean +_ SEM) as a function of cumulatively increasing cevadine concentrations (3, 30, 100 IxM 
or  1,  10,  30  I~M) from  the  indicated  number  of  cells.  ECs0  is  4  p,M. (C)  Plot  of  %~] 
(mean _+ SEM) from the experiments shown in B; the straight line corresponds to the average 
of all Ttail values (49 ms). 
Competition between Veratridine and Cevadine 
If veratridine and cevadine interact with the same site or overlapping sites of the Na 
channel, two easily testable predictions can be made for whole-cell Na current. 
(a) Combining veratridine and cevadine at low concentrations such that each drug 
binds to  a  small, e.g.  20%,  fraction of the  Na channels should induce a  tail current HONERJ~GER ET AL.  Intracellular  Action of Veratridine and Cevadine  711 
with  an  initial  amplitude  corresponding  approximately to  the  sum  of amplitudes 
produced by each alkaloid component alone and with a biexponential decay in which 
the short time constant should correspond to cevadine dissociation ('r ~  50 ms) and 
the long time constant to veratridine dissociation ('r --  230 ms). 
(b) Adding a high (saturating) concentration of cevadine to a saturating concentra- 
tion ofveratridine should have little effect on the initial amplitude of the tail current, 
because  cevadine  cannot  recruit  additional  Na  channels  but  can  only  replace 
veratridine  at  a  fraction  of  the  Na  channels.  This  argument  implies  that  the 
conductance and open probability ofveratridine- and cevadine-modified Na channels 
are  identical.  In  previous  experiments  we  found  the  elementary  current  level  of 
cevadine-modified  Na  channels  at  -30  mV  to  be  indeed  identical  to  that  of 
veratridine-modified channels (Honerj~ger, Dugas, and Wang,  1990) and the gating 
kinetics  to  be  similar.  Furthermore,  cevadine  should  speed  the  decay  of  the 
veratridine-induced  tail  current  because  the  cevadine  molecules which  bind  to  a 
fraction of Na channels at the expense of veratridine-modified channels will dissoci- 
ate about five times faster than veratridine upon repolarization. As in prediction (a), 
the  tail  current  should  then exhibit a  biexponential  time course with  Ttail'S corre- 
sponding to cevadine and veratridine, respectively. 
As shown by Fig. 7 and Table IV, both predictions were experimentally confirmed. 
Since  saturation  with  veratridine  or  cevadine  is  difficult  to  achieve  at  normally 
inactivating Na channels, all experiments were performed in the presence of 1 ~M 
BDF 9145. 
(a) Superfusion with a mixture of I  ~M veratridine and 2 ~M cevadine produced a 
biexponentially decaying tail  current with  time  constants  (60  and  204  ms)  corre- 
sponding closely to those observed with cevadine or veratridine alone (Fig. 7 A ). The 
initial  amplitude  of the  tail  current was  63%  of that  observed with  a  saturating 
cevadine  concentration.  This  is  in  good  agreement  with  the  50%  resulting  from 
adding  the  effects of  1  ~M  veratridine  (Fig.  3  in  Zong  et  al.,  1992)  and  2  p,M 
cevadine (Fig. 7 B) alone. 
(b) The addition of 100 ~M cevadine to a  saturating concentration of veratridine 
(30  ~M)  increased  the  decay rate  of the veratridine-induced tail current markedly 
with little effect on its initial amplitude (Fig. 7 B). The monoexponential decay in the 
presence of veratridine ('r -- 212 ms) was converted into a biexponential decay with 
an additional fast component corresponding to cevadine dissociation (~" =  40 ms) and 
a  nearly  unchanged  slow  component  (7--226  ms)  corresponding  to  veratridine 
dissociation. The ratio of fast to slow components of tail current decay was  3.0  in 
good agreement with the ratio of molar cevadine to veratridine concentration (3.3). 
This agreement is predicted by the near equipotency of cevadine with respect to their 
effect on/tail in our experiments. Table IV lists  this experiment together with three 
trials using 30  ~M  cevadine. These experiments yielded results also in accordance 
with the prediction for combining saturating alkaloid concentrations. Adding 30 I~M 
cevadine to 30 ~M veratridine had little effect on the initial amplitude of tail current, 
but  induced a  component of fast decay (amounting  to  40%  of total decay) at  the 
expense of the  slow  veratridine-induced decay. The protection against  veratridine 
modification  provided  by  cevadine  is  clearly  visualized  by  the  cevadine-induced 
decrease of tail  current  amplitude  measured  86  ms  after repolarization,  at which nA 
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FIGURE 7. HONERJ,~GER ET AL.  lntracellular Action of Veratridine and Cevadine 
TABLE  IV 
Fitted Parameters  for Tail Current Amplitude, I, and Time Constant, ~, Induced by 
Veratridine Alone and by the Combination of Veratridine and Cevadine 
713 
t*  I~+1" 
Cell  Iv  "rv  lc  1~*  "re  "r~* 
I,+l*  L 
-hA  ms 
30 p,M veratridine 
Z141  2.39  308 
Z154  0.94  256 
Z155  0.53  193 
Mean -+ SEM 
30 ~M veratridine 
ZI21  1.69  212 
Mean -+ SEM  242 ±- 26 
-hA  -hA  ms  ms 
30 ~M veratridine + 30 ~M cevadine 
1.22  1.46  0.54  46.5  314  1.12 
0.26  0.75  0.74  63.6  278  1.08 
0.31  0.35  0.53  28.4  217  1.26 
--  --  0.60 -  0.07  --  --  1.15 ± 0.06 
30 ~M veratridine +  100 IzM cevadine 
1.17  0.39  0.25  40.0  226  0.93 
--  --  --  44 ±- 7  259 +- 23  (n = 4) 
Tail currents for veratridine only were fitted by the function  -Iv ' exp (-t/"rv), for veratridine + cevadine by 
the function -Ic • exp (-t/"rc) -  Iv*" exp (-t/'r*  0. 
point  most  of the  fast  cevadine-induced  component  has  decayed  and  veratridine- 
modified channels  determine  the tail current  (Fig.  7 B, inset). 
DISCUSSION 
This study has defined in further detail the veratridine recognition site of the cardiac 
Na channel  by experimental  results  that  are  consistent with  the protonated  from  of 
veratridine  being  the  active  molecular  species  and  the  intracellular  aspect  of the 
channel  macromolecule  being the  site at which  the alkaloid  acts.  In the  accompany- 
ing paper  (Zong et al.,  1992)  we have shown  the saturable  nature  of the veratridine 
effect  on  whole-cell  Na  current.  Our  present  evidence  that  cevadine  reduces  the 
veratridine-induced  tail current in the presence of a  saturating veratridine concentra- 
tion  strengthens  the  concept  that  veratridine  binds  to  a  limited  number  of sites  on 
Figure  7.  (opposite)  Interaction between low concentrations (A) and high concentractions (B) of 
veratridine and cevadine. Records are from two different cells, both of which were additionally 
treated with 1 I~M BDF 9145.  (A) Na current elicited by 50-ms depolarization to -30  mV from 
-100  mV  holding  potential  (0.2  Hz)  after  2-min  equilibration  with  a  mixture  of  I  I~M 
veratridine and 2  ~,M cevadine. Tail current  amplitude was 63% of maximum l,~i~ determined 
subsequently in the presence of 1 ~M BDF 9145 and 30 I~M cevadine (not shown). Tail current 
(nanoamperes) as a function of time t in seconds was fitted by the biexponential function -1.24 
exp (-t/0.060)  -  0.47 exp (-t/0.204). The second term (veratridine component) is shown as a 
dotted line. (B) Na current elicited by identical pulse protocol after l-rain equilibration with 30 
p,M veratridine (a) and after 2-rain subsequent exposure to a mixture of 30 IzM veratridine and 
100 p,M cevadine (b). Note the reduction of tail current by cevadine. Tail current a was fitted by 
the monoexponential  function  -1.69  exp (-t/0.212)  and  tail current  b by the biexponentiai 
function  -1.17  exp (-t/0.040)  -  0.39  exp (-t/0.226).  Smooth lines are fitted functions and 
vertical lines mark start of fit. (Inset)  Tail current amplitude measured 86 ms after repolariza- 
tion plotted for the time interval immediately before and after addition of cevadine. 714  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  99  •  1992 
the cardiac cell and suggests a competitive interaction between these two ceveratrum 
alkaloids which  differ only in  the  nature  of their C-3  ester  substituent.  Although 
previous studies  did  not  explicitly attempt  to identify the  active form  and  site  of 
action of veratridine, we shall discuss related previous experimental contributions on 
the mode of action of veratridine and the three other activator ligands thought to 
share their site of action, called site 2, with veratridine: batrachotoxin, grayanotoxins, 
and aconitine (Catterall,  1977). We conclude by describing our current view of the 
molecular mechanism  of action veratridine and  other ceveratrum alkaloids  at  the 
cardiac Na channel. 
Effect of pH on the Action of Veratridine and Batrachotoxin 
Our results are in agreement with Ulbricht's (1969) finding of a stronger veratridine 
effect at  pHo  8.1  as  compared  with  pHo  7.2,  where  the  effect was  measured  as 
depolarization  of the  resting  membrane  in  the  frog  node  of Ranvier.  Warnick, 
Albuquerque, Onur, Jansson,  Daly, Tokuyama, and Witkop  (1975) investigated the 
pHo dependence of action of batrachotoxin, a Na channel activator thought to share 
its  site  of action  with  veratridine  (Catterall,  1977).  Increasing  pHo in  the  range 
6.0-9.0 increased the extent and rate of the depolarization induced by batrachotoxin 
in  rat  skeletal  muscle,  the  depolarization  reflecting  persistent  activation  of  Na 
channels. To Warnick et al. (1975) these results suggested "that the most active form 
of batrachotoxin is the free base." 
Our results confirm this interpretation for extracellularly applied veratridine, but 
the true active form of batrachotoxin, like that of veratridine, could be the cationic 
form acting intracellularly with the free base form providing transmembrane access 
for the alkaloid during extracellular application. 
Could pH-dependent alterations of the veratridine receptor rather than changes of 
the ionization of veratridine explain our results? The slow increase of the veratridine 
effect in  response  to a  fast alkalinization  of the  extracellular superfusate  (Fig.  2), 
which  would  immediately  affect  the  ionization  of  extracellular  residues  on  the 
channel, argues against sensitivity to pHo of the veratridine binding site in the range 
7.3-8.3. 
During intracellular veratridine application (and simultaneous extracellular appli- 
cation  in  order to  compensate  the  loss  of veratridine across  the  sarcolemma)  the 
veratridine effect on cells with a pHi of 7.3 did not differ from that on cells with a pHi 
of 8.3. Since the concentration of protonated veratridine molecules changes by  < 5% 
over this pH range, we propose that this form of veratridine is the active form. If, 
contrary to our view, intracellular veratridine were active in its free base form, the 
increase  of pHi by one  unit,  which  increases uncharged  veratridine concentration 
10-fold, should have blocked 90% of the veratridine receptors in order to account for 
the  observed  unchanged  effect. A  block by  this  extent  seems  very unlikely  since 
ionization of most amino acids changes by  < 1% over this pH range and that of the 
most sensitive residue, cysteine (pKa -- 8.3), by only 40%. 
Kinetics  of the  Veratridine  Effect 
We have shown that the effect of superfused veratridine on a  single cardiomyocyte 
develops  over  1-2  rain,  although  the  extracellular veratridine  concentration was HONERJXGER ET AL.  IntraceUular  Action of Veratridine and Cevadine  715 
established within 0.1 s by the microsuperfusion device. The effect, measured as tail 
current amplitude  every 5  s,  monitors the  number of Na  channels  that  react with 
veratridine  during  the  immediately  preceding  50-ms  pulse  (Sutro,  1986;  Hille, 
Leibowitz, Sutro, Schwarz, and Holan, 1987; Zong et al.,  1992). The slow onset of the 
effect thus shows that veratridine has to diffuse to and accumulate in a  space other 
than the extracellular space in order to be reactive. 
This conclusion confirms a kinetic analysis on the frog node of Ranvier Na current 
(Ulbricht,  1972) which  showed that  the onset of veratridine action during alkaloid 
superfusion is too slow to be accounted for by diffusion to the extracellular surface of 
the axolemma. 
Defining the Intracellular Site of Action 
During extracellular application, we have shown a close correlation between the free 
base  form  of veratridine  and  its  effect on  Na  current when  pH  was  changed  at 
constant  veratridine  concentration  (Fig.  2)  or  when  pH  and  total  veratridine 
concentration  were  altered  such  that  the  free  base  concentration  remained  un- 
changed (Fig. 3). During intracellular application, a route that has previously been 
shown in the squid giant axon to be effective for ceveratrum alkaloids (Meves,  1966; 
Honerj~iger,  1973), batrachotoxin (Narahashi and Deguchi,  1971), and grayanotox- 
ins  (Seyama and Narahashi,  1973) and for aconitine in neuroblastoma cell outside- 
out patches  (Negulyaev, Vedernikova, and  Savokhina,  1990), we have seen a  close 
correlation between  the  charged  and  presumably  membrane-impermeant  form  of 
veratridine and its effect on Na current (Fig. 4; Table I), suggesting that veratridine 
acts in its protonated from at the intracellular side of the Na channel. 
Evidence from earlier work points to an intracellular site of action of site 2 ligands. 
The effect on Na current of the semisynthetic ceveratrum alkaloid germine-3-acetate, 
applied extracellularly to an intracellularly perfused squid axon, is inversely related 
to the rate of intracellular perfusion, suggesting that the latter effectively dilutes the 
alkaloid  concentration  at  its  intracellular  site  of action  (Honerj~iger,  1973).  This 
relationship has been confirmed for the depolarizing effects of veratridine, batracho- 
toxin,  aconitine,  and  a  grayanotoxin (Seyama, Yamada,  Kato,  Masutani,  and  Ha- 
mada,  1988).  These  authors  conclude  that  these  toxins  "may  reach  a  site  only 
accessible  from  the  internal  surface  of the  membrane"  in  accordance  with  our 
conclusion  concerning  germine-3-acetate  (Honerjiiger,  1973)  and  the  conclusion 
derived in the present work for veratridine. 
Defining the active form and  site of action of weak bases,  such as veratridine, is 
complicated by  their  transmembrane  diffusion  and  subsequent  protonation which 
occurs irrespective of extra- or intracellular application. Principally, veratridine could 
act in both its  molecular forms, each either binding  to one common site or to its 
separate  site  (see  Howe  and  Ritchie,  1991).  However,  the  fact  that  veratridine- 
modified  Na  currents  are  well  described  by  assuming  a  single  association  and 
dissociation rate constant at  both the macroscopic (Zong et al.,  1992)  and  micro- 
scopic levels (Wang, Dugas, Armah, and Honerj~iger, 1990) makes these theoretical 
possibilities very unlikely. For defining the single active molecular species, variation 
of extracellular or intracellular pH is a valuable approach, and pH effects other than 
those  on  the  degree  of  veratridine  ionization  seem  unlikely.  Nevertheless,  an 716  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  99-  1992 
independent  method  to defne the  site  of action  of membrane-permeant  channel 
ligands seems desirable. 
The  rate  of ligand  association  to  its  binding  site  from  the  aqueous  solution 
surrounding the target protein is controlled by its diffusion coefficient, and the rate 
of tigand  dissociation  into  the  aqueous  medium  is  also  affected by  the  diffusion 
coefficient  (Schurr,  1970).  Since  the  diffusion  coefficient  is  inversely  related  to 
viscosity, an increase in viscosity of the reaction medium slows both ligand association 
and dissociation rates (Schurr,  1970). Miller (1990) has exploited these principles in 
an  electrophysiological study on the  possible  diffusional control of charybdotoxin 
binding to single Ca-activated K channels. 
Inspired  by  the  article  of Miller  (1990)  we  have  adopted  the  viscosity  test  to 
determine  the  sidedness  of veratridine  action  in  single  cardiomyocytes  in  the 
whole-ceU  clamp  configuration.  The  monoexponential  decay  of the  veratridine- 
induced  tail  current,  which  is  particularly  suitable  for  quantitative  evaluation,  is 
thought to reflect dissociation of veratridine molecules from Na channels to which it 
bound during the preceding activating pulse (Sutro, 1986; Hille et al., 1987; Wang et 
al.,  1990;  Zong et al.,  1992).  If this view is  correct and  if veratridine dissociation 
occurs  from  an  intracellular  binding  site  of the  Na  channel  into  the  cytoplasmic 
microenvironment, then Ttail should be sensitive to intracellular, but not to extracel- 
lular, viscosity. 
Both  predictions  were  found  to  be  correct,  and  the  sensitivity  to  intracellular 
viscosity was quantitatively consistent with a direct relation between ~tail and intracel- 
lular  veratridine  dissociation  rate  (Fig.  5;  Table  III).  The  results  suggest  that 
veratridine does not dissociate into the extracellular space or into the lipid microen- 
vironment of the Na channel but exclusively into the intracellular space. 
In addition  to defining the  sidedness of veratridine action,  the viscosity effect is 
valuable  in  identifying tail current  decay as  a  direct consequence of the  chemical 
process of veratridine dissociation from its receptor. This view, originally developed 
by Sutro (1986), has recently been challenged by Rando (1089). After a conditioning 
pulse that activates Na channels and induces a veratridine modification in the frog 
node of Ranvier, he observed peak Na current to recover more slowly than would be 
expected if veratridine unbinds in parallel to tail current decay making Na channels 
immediately reavailable for voltage activation. According to Rando  (1989),  the  tail 
current therefore reflects transition of veratridine-modified open Na channels  into 
closed  ("inactivated"),  veratridine-bound  channels  from  which  veratridine  would 
dissociate much more slowly and would be undetectable by electrical measurement. 
Two  independent  arguments  obtained  on  cardiac  cells  are  at  variance  with  this 
interpretation: the viscosity effect shown here and the behavior of single Na channels 
comodified with  the allosteric activator BDF 0145  (Wang et al.,  1990).  The latter 
study has  shown  that  a  given  single  Na  channel,  after going  through  the  typical 
low-conductance, burst-like  modification induced  by veratridine,  does  not  enter a 
closed  ("inactivated")  state  but  is  immediately  available  for  another  veratridine 
modification with a latency inversely related to the veratridine concentration bathing 
the intracellular membrane surface. The termination of the veratridine-induced Na 
current  can  therefore be  equated with  veratridine  dissociation  and  its  onset with 
veratridine association (Wang et al.,  1990). HONERJ.g,  GER ET AL.  Intracellular  Action of Veratridine and Cevadine  717 
We have now provided four independent lines of evidence that support the concept 
of an intracellular site of action of the protonated form of veratridine:  (a)  the slow 
onset of action during extracellular application; (b) the close association of the effect 
with  the free base  and  presumably membrane-permeant form during extracellular 
application and with the protonated presumably membrane-impermeant form dur- 
ing  intracellular application;  (c) the  increase  of "l'tail in  response  to  an  increase  of 
intracellular, but not extracellular, viscosity; and (d) in a separate study on veratridine 
reaction dynamics at activated single cardiac Na channels, we determined a veratri- 
dine association rate of 4.3 x  106 M-Is-1 with the drug applied intracellularly (Wang 
et al.,  1990), a value similar to that observed in single neuronal Na channels (Barnes 
and Hille, 1988). If calculated for the free base form rather than for total veratridine 
concentration,  and  disregarding  the  possibility  of  free  base  accumulation  in  a 
hydophobic space, a value of 8.6  x  l0  s M-is -l is obtained. This value is close to the 
maximum of a  diffusion-controlled encounter frequency and would imply that  the 
free  base  form  of veratridine  binds  to  the  receptor  site  during  each  diffusional 
collision irrespective of its conformation and its orientation relative to that site, and 
irrespective  of the  momentary  conformation  of the  veratridine-binding  site.  This 
seems very unlikely for a recognition site that interacts specifically with at least one 
group of the alkaloid, the C-3 ester substituent, as shown by the difference between 
veratridine and cevadine dissociation rates (see below). Thus, we conclude that the 
association rate constant is consistent with the protonated form of veratridine being 
the reactive molecular species. 
Effect of Cevadine 
In  addition  to  the  protonated  nitrogen,  the  veratric  ester  group  of veratridine 
appears  to play a  decisive role in  stabilizing  the veratridine-Na channel complex. 
This interpretation is based on the shorter ~t~il induced by cevadine, indicating a five 
times faster dissociation from the Na channel of this alkaloid (Fig. 6) which carries a 
less lipophilic ester group (angelic acid) at C-3 and probably binds to the same site as 
veratridine  as  suggested  by  their  mutually  exclusive  effects  (Fig.  7 B;  Table  IV). 
Veracevine,  the  unesterified alkamine,  shows  a  still  faster  dissociation  rate  in  the 
millisecond range (Honerj~iger et al.,  1990).  The lipophilicity provided by the C-3 
substituent  decreases in  the order veratridine  >  cevadine  >>  veracevine as  deter- 
mined by the partitioning between water and chloroform phases (B0ch,  1976). The 
shorter "trail induced by cevadine in comparison to veratridine (49 vs. 226 ms) in the 
cardiomyocytes confirms  the  kinetic  difference found  for frog muscle  Na  current 
(Leibowitz, Schwarz,  Holan,  and  Hille,  1987)  and  is  also  in  line with  earlier work 
showing that cevadine induces shorter-lasting  afterdepolarizations in various nerve 
preparations than in veratridine (Shanes, 1952; Honerj~iger, 1973). The possibility of 
competitive  interactions  between  ceveratrum  alkaloids  has  not  been  previously 
examined by electrophysiological experiments. In Na flux studies on neuroblastoma 
cells, where cevadine itself does not increase Na influx, cevadine has been shown to 
reduce Na  channel  activation by veratridine in  line with  a  competitive interaction 
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Molecular Aspects 
The most detailed hypothesis for the molecular mechanism of action of veratridine 
has been developed by Hille et al. (1987). According to these authors, the conforma- 
tional changes associated with the opening of the Na channel macromolecule expose 
a receptor for veratridine "that we suppose faces the hydrophobic interior of the lipid 
bilayer  ....  When  agonist  binds  to  the  exposed  receptor,  it  could  form  a  wedge 
between domains  and  stabilize  the  open  state while distorting  the  macromolecule 
sufficiently to enlarge the selectivity filter. This stabilization hinders channel closing 
by either of the two normal mechanisms, deactivation or inactivation. If the modified 
channel does close, the receptor pocket narrows and presses on the drug. This strain 
favors reopening  of the  modified  channel  even  at  potentials  more  negative  than 
usual." 
Our  experiments  suggest  that  the  veratridine  receptor  faces  the  intracellular 
aqueous phase rather than the hydrophobic interior of the cell membrane and that it 
reacts with positively charged intracellular veratridine rather than intramembraneous 
nonionized alkaloid molecules. By analogy with other cation-binding receptors, the 
veratridine receptor is likely to contain a  negatively charged residue to form a  salt 
bridge with the ammonium group of veratridine. In addition, we propose an adjacent 
lipophilic group that forms a hydrophobic bond with the veratric acid ester group in 
veratridine or, in less stable fashion, with the angelic acid ester group in cevadine. 
These proposed structural features of the veratridine binding site could be verified 
and  identified  at  the  amino  acid  level  by  probing  the  veratridine  effect on  Na 
channels exposed to appropriate site-directed antibodies or modified by site-directed 
mutagenesis. The intactness of the intracellular peptide loop connecting segment 6 
of  domain  III  with  segment  l  of  domain  IV,  probed  by  liganding  it  with  a 
site-directed  antibody  (Vassilev,  Scheuer,  and  Catterall,  1988)  or  by  cutting  the 
coding mRNA for this loop (Stiihmer, Conti, Suzuki, Wang, Noda, Yahagi, Kubo, and 
Numa,  1989), has been shown to be essential for the fast inactivation gating process 
in  native  skeletal  muscle  Na  channels  and  a  cloned  rat  brain  sodium  channel, 
respectively.  It  is  therefore possible  that  cationic veratridine  binds  to  one  of the 
known carboxylates on this loop (Asp-1486, Glu-1491, or Glu-1492 in the rat heart 
Na channel), which have been shown to be highly conserved in a wide range of Na 
channel subtypes in different species (Rogart et al.,  1989). A possible role of these 
two glutamates  in inactivation gating has recently been considered on the basis  of 
negative  results  when  positive  charges  of  the  III-IV  linker  were  eliminated  by 
site-directed  mutagenesis  (Moorman,  Kirsch,  Brown,  and Joho,  1990).  Molecular 
identification of the veratridine recognition site should reveal a transiently accessible 
region of the  Na channel macromolecule, exposed by Na channel opening,  that is 
directly or allostericaUy coupled to several functions including inactivation, deactiva- 
tion, conductance, and ion selectivity. 
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